Radioiodine therapy of benign thyroid disorders: What are the effective thyroidal half-life and uptake of 131I?

Nuclear Medicine Communications

Volumn 31, Issue 3, 2010, Pages 201-205

  Kobe, Carsten ^a   Eschner, Wolfgang ^a   Wild, Markus ^a   Rahlff, Ilka ^a   Sudbrock, Ferdinand ^a   Schmidt, Matthias ^a   Dietlein, Markus ^a   Schicha, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Dosimetry; Half life; Hyperthyroidism; Radioiodine therapy; Thyroid; Uptake

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; GOITER; GRAVES DISEASE; HUMAN; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; NONTOXIC GOITER; RADIATION DOSE; THYROID ADENOMA; TOXIC GOITER;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GOITER; GRAVES DISEASE; HALF-LIFE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOTHERAPY; THYROID DISEASES; THYROID NEOPLASMS; TIME FACTORS;

EID: 76749094593     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328333d303     Document Type: Article

References (20)

1. Weetman AP. Radioiodine treatment for benign thyroid diseases. Clin Endocrinol (Oxf) 2007; 66:757-764.
2. Jarlov AE, Hegedus L, Kristensen LO, Nygaard B, Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile? Clin Endocrinol (Oxf) 1995; 43:325-329.
3. Leow MKS, Loh KC, Zhu M, Chan SP, Sundram FX. Iodine-131 therapy for hyperthyroisism prescribed by endocrinologist - our preliminary experience. Exp Clin Endocrinol Diab 2008; DOI10.1055/s-0028-1102919; [Epub ahead of print]
4. Dietlein M, Dressler J, Eschner W, Lassmann M, Leisner B, Reiners C, Schicha H. Procedure guideline for radioiodine test (version 3). Nuklearmedizin 2007; 46:198-202. (Pubitemid 47612285)
5. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden ES. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 2003; 88:978-983.
6. Nüchel C, Boddenberg B, Schicha H. The value of the radioiodine uptake test for the calculation of therapeutic doses for benign thyroid disorders. Nuklearmedizin 1993; 32:91-98.
7. Wartofsky L. Low remission after therapy for Graves disease. JAMA 1973; 226:1083-1088.
8. Bernhard JD, McDonald RA, Nesmith JA. New normal ranges for the radioiodine uptake study. J Nucl Med 1970; 11:449-451.
9. Bachmann J, Kobe C, Bor S, Rahlff I, Dietlein M, Schicha H, Schmidt M. Radioiodine therapy for thyroid volume reduction of large goitres. Nucl Med Commun 2009; 30:466-471.
10. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. Volumetric analysis of thyroid lobes by real-time ultrasound. Dtsch Med Wschr 1981; 106:1338-1340.
11. Snyder WS, Ford MR,Warner GG,Watson SB. MIRD Pamphlet No. 11: S absorbed dose per unit cumulated activity for selected radionuclides and organs (PART2). Reston, VA: Society of Nuclear Medicine; 1975.
12. Alexander EK, Larsen PR. High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2002; 87:1073-1077.
13. Catargi B, Leprat F, Guyot M, Valli N, Ducassou D, Tabarin A. Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and other possible factors affecting outcome. Eur J Endocrinol 1999; 141:117-121.
14. Boelaert K, Syed AA, Manji N, Sheppard MC, Holder RL, Gough SC, Franklyn JA. Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidsim. Clin Endocrinol (Oxf) 2009; 70:129-138.
15. Brent GA. Clinical practice. Graves' disease. N Engl J Med 2008; 358:2594-2605.
16. Jönsson H, Mattsson S. Excess radiation absorbed doses from nonoptimised radioiodine treatment of hyperthyroidism. Radiat Prot Dosimetry 2004; 108:107-114. (Pubitemid 38324494)
17. Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H. Graves' disease and radioiodine therapy: is success of ablation dependent on the achieved dose above 200 Gy? Nuklearmedizin 2008; 47:13-17.
18. Rendl J, Juhran N, Reiners C. Thyroid volumes and urinary iodine in German school children. Exp Clin Endocrinol Diab 2001; 109:8-12.
19. Bockisch A, Jamitzky T, Derwanz R, Biersack HJ. Optimized dose planning of radioiodine therapy of benign thyroidal diseases. J Nucl Med 1993; 34:1632-1638.
20. Sisson JC, Avram AM, Rubello D, Gross MD. Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science? Eur J Nucl Med Mol Imaging 2007; 34:1129-1130.